algorithm
Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival in Cancer Patients
Premium
WIN Consortium researchers have shown that a prototype "digital display precision predictor" may identify patents who will live longer on treatments without progression.
The rate at which NGS-based algorithms generate obsolete trial matches is a system-wide information shortcoming, not a reflection of the tests themselves.
Allarity Therapeutics Begins European Study of Ixempra for Biomarker-Selected Breast Cancer Patients
The Phase II trial will enroll metastatic breast cancer patients who are deemed likely to respond to the agent based on Allarity's Drug Response Predictor.
PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment
Premium
The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ.
Relay Therapeutics Uses Protein Motion Simulation to Develop Highly Selective Precision Cancer Drugs
Premium
The company, which raised $460 million in an IPO in July, has developed a pipeline of selective agents, two of which have advanced to Phase I clinical trials.